U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid
  1. Drug Safety and Availability

FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid

NSAIDs may cause rare kidney problems in unborn babies

9/1/2022 Update: The unapproved prescription NSAIDs salsalate and choline magnesium trisalicylate were added to Table 1.

10/16/2020 Update: This does not apply to NSAIDs administered directly to the eye.

Español Drug Safety Podcast

10-15-2020  FDA Drug Safety Communication

Drug Safety Communication (PDF - 289KB)

Related Information

Contact FDA

For More Info
855-543-DRUG (3784) and press 4
druginfo@fda.hhs.gov

Report a Serious Problem to MedWatch
Complete and submit the report Online.
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

Subscribe to Email Updates

Subscribe to Drug Safety Communications

Back to Top